Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$9.95 - $12.27 $59 - $73
-6 Reduced 50.0%
6 $0
Q1 2022

Apr 19, 2022

BUY
$9.81 - $15.4 $117 - $184
12 New
12 $0
Q4 2021

Feb 04, 2022

SELL
$12.09 - $14.68 $5,972 - $7,251
-494 Closed
0 $0
Q3 2021

Oct 13, 2021

SELL
$13.25 - $15.13 $410 - $469
-31 Reduced 5.9%
494 $7,000
Q2 2021

Jul 27, 2021

BUY
$12.97 - $16.15 $4,798 - $5,975
370 Added 238.71%
525 $8,000
Q4 2020

Jan 29, 2021

BUY
$14.3 - $18.74 $2,216 - $2,904
155 New
155 $3,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Joseph P. Lucia & Associates, LLC Portfolio

Follow Joseph P. Lucia & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.